HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.
5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Cardiovascular Engineering and Technology
Cardiovascular Engineering and Technology
Cardiovascular engineering is an area of computation medical technology that focuses on the study of cardiovascular illnesses and disorders, including basic science and experimental to clinical applications, and spans the range from the molecular to the whole body
Cardiovascular Technology: It refers to the technologies that are used to help and diagnose conditions associated with cardiovascular disease and diseases. These technologies are also utilized to help physicians diagnose and treat cardiac (heart) and peripheral vascular disorders (blood vessel), as well as during open-heart surgeries and pacemaker insertion surgeries.
Committee Members
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Syed Raza
Awali Hospital, Bahrain Heart Congress 2027 Speakers
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Syed Raza
Awali Hospital, Bahrain
Uwe Peter Tigor
Auxilius Pharma, United StatesSubmit your abstract Today
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India